Drug Safety in Episodic Migraine Management in Adults. Part 2: Preventive Treatments

AbstractPurpose of ReviewThe aim of this review is to aid in decision-making when choosing safe and effective options for preventive migraine medications.Recent FindingsIn Part 2, we have compiled clinically relevant safety considerations for commonly used migraine prophylactic treatments. Preventive treatment of episodic migraine includes nonspecific and migraine-specific drugs. While medications from several pharmacological classes –such as anticonvulsants, beta-blockers, and antidepressants–have an established efficacy in migraine prevention, they are associated with a number of side effects. The safety of migraine-specific treatments such as anti-CGRP monoclonal antibodies and gepants are also discussed.SummaryThis review highlights safety concerns of commonly used migraine prophylactic agents and offers suggestions on how to mitigate those risks.
Source: Current Pain and Headache Reports - Category: Neurology Source Type: research